Tour de France champion Chris Froome will begin his season at the Ruta del Sol in Spain in just over a week.
The five-day stage race in Andalusia will be Froome's first appearance since his third-place finish in the time trial at the road world championships in Norway on September 20.
That was the day he learned he had returned an adverse analytical finding for the asthma drug salbutamol two weeks before, on his way to victory at the Vuelta a Espana.
That victory was the second half of Froome's historic Grand Tour double, having already won his fourth Tour de France in July.
Froome and Team Sky are presenting their case to the cycling's governing body, the UCI, about the adverse finding.
News that makes sense
Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.
"I'm confident that we will be able to get to the bottom of what has happened and I'm working hard with the team to do that," Froome said.
Team Sky principal Sir Dave Brailsford added: "We all recognise that these are difficult circumstances but it's important for all sides that this process is conducted fairly before a final conclusion is reached.
"It is a complex situation but we're working as hard as we can with Chris to resolve things as soon as possible."
